News & Videos - CONTEXTVISION AB [CHIX]

INVITATION We are pleased to invite you to a presentation of Contextvision AB and its 2 nd quarter and half year 2020 figures and give an update on the company’s development and ongoing projects. The presentation will be held as an online webinar on Thursday, September 24th at 11:30. We are very proud of Context Vision’s developments during 2020 and look forward to sharing an update of the major achievements. Fredrik Palm, CEO, and Ann-Charlotte Linderoth, CFO, will represent the management....

STOCKHOLM – August 28, 2020 – Ola Lindblad, VP Medical Imgaing of ContextVision, has on August 27, 2020 purchased 1,800 shares in ContextVision AB at an average price of NOK 22.37 per share. After the transaction, Mr Lindblad holds a total of 6,300 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About ContextVision ContextVision is a medical technology software company...

STOCKHOLM – August 17, 2020 – Fredrik Palm, CEO of ContextVision, has on August 17, 2020 purchased 200 shares in ContextVision AB at an average price of NOK 245 per share. After the transaction, Mr Palm holds a total of 2,820 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and...

STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announces key information relating to the share spilt after a decision by the Board of Directors as of August 12 th 2020. Reference is made to the extraordinary general meeting of ContextVision, held on August 5th, 2020 where it was decided to increase the number of shares in the company by dividing each share into ten shares (share split 10:1)....

ContextVision - Delårsrapport 2020 Attachment ContextVision delårsrapport 2020...

STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today reports a progressive second quarter. INIFY® Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE-mark status, paving the way for a strong entry into the fast-growing digital pathology market. In addition, the company continues to spearhead the image enhancement market with...

On the 5th of August 2020, ContextVision held an Extraordinary General Meeting in Stockholm. The Board's proposal for adoption of new articles of association was approved The Board's proposal for decision on the share split of the company's share was approved No other matters were processed at the meeting. For further information, please contact: Ann-Charlotte Linderoth (CFO) tel +46 (0)8 7503550, e-mail [email protected] ### About ContextVision ContextVision is a medical...

STOCKHOLM – June 29, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced that its first digital pathology product in a planned portfolio has been granted CE mark status. This means that INIFY ® Prostate Screening is now available for routine clinical use within the European Union. “I am proud of the great performance by our outstanding multidisciplinary team in reaching this company milestone. Healthcare...

STOCKHOLM – June 24, 2020 – ContextVision hereby invites shareholders to an Extraordinary General Meeting on August 5, 2020. Please find attached the invitation including agenda and details on how to register. Please contact: [email protected] for any questions regarding the Extraordinary General Meeting. For inquiries, please contact CFO Ann-Charlotte Linderoth E-mail: [email protected] ### About ContextVision ContextVision is a medical technology...

Stockholm, June 12 th , 2020 – Today ContextVision presented the company at a webinar arranged by SpareBank 1 Markets in Norway. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About...

STOCKHOLM – May 19, 2020 – Fredrik Palm, CEO of ContextVision, has on May 19, 2020 purchased 120 shares in ContextVision AB at an average price of NOK 155 per share. After the transaction, Mr Palm holds a total of 2620 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About ContextVision ContextVision is a medical technology software company specialized in image analysis and...

STOCKHOLM – May 12, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the strengthening of its board of directors. Martin Ingvar, Professor of Integrative Medicine at Karolinska Institute Sweden and founding member of International Consortium for Health Outcome Measurements (ICHOM), was elected as new member of the board at the annual general meeting. The company will soon enter the rapidly emerging digital...

On the 6th of May 2020, ContextVision held its ordinary Shareholders' Annual General Meeting in Stockholm. The annual financial report regarding 2019 was presented and approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and the Board of Directors were discharged from liability. The proposed guidelines for remuneration to the Board of Directors and senior executives was approved. Board compensation was...

Stockholm, May 6, 2020 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 30,500 shares on April 28, at an average price of 120 NOK/share, in accordance with the rules related to the foundation. The sold shares were originally purchased in 2015, and according to the rules they must be sold after a period of 3 full calendar years, the...

STOCKHOLM – April 29, 2020 – Fredrik Palm, CEO of ContextVision, has on April 28, 2020 purchased 1000 shares in ContextVision AB at an average price of NOK 120 per share. After the transaction, Mr Palm holds a total of 2500 shares in ContextVision AB. Monsun AS, controlled by Magne Jordanger, member of the board of ContextVision, has on April 28, 2020 purchased 2000 shares in ContextVision AB at an average price of NOK 120 per share. After the transaction, Monsun AS holds a total of 2 300...

STOCKHOLM – April 23, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced record sales and EBITDA, mainly driven by the company’s medical imaging business, despite the current global challenges. ContextVision’s first digital pathology solution continues to accelerate toward market availability. Medical Imaging Sales in Q1 ended at 29.2 MSEK, a substantial increase of 38.4% compared to the first quarter in...

STOCKHOLM – April 2, 2020 – ContextVision hereby invites shareholders to the Annual General Meeting on May 6, 2020. Please find attached the invitation including agenda and details on how to register. Please contact: [email protected] for any questions regarding the AGM. For inquiries, please contact CFO Ann-Charlotte Linderoth E-mail: [email protected] ### About ContextVision ContextVision is a medical technology software company specialized in image...

STOCKHOLM – March 20, 2020 – Monsun AS, controlled by Magne Jordanger, member of the board of ContextVision, has on March 19, 2020 purchased 49 250 shares in ContextVision AB at an average price of NOK 67,27 per share. After the transaction, Monsun AS holds a total of 2 298 000 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About ContextVision ContextVision is a medical...

STOCKHOLM – March 17, 2020 – Fredrik Palm, CEO in ContextVision, has on March 13, 2020 purchased 300 shares in ContextVision AB at an average price of NOK 65 per share. After the transaction, Mr Palm holds a total of 1500 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com . ### About ContextVision ContextVision is a medical technology software company that specializes in image analysis...

Stockholm, March 10 th , 2020 – Today ContextVision held a company presentation in Oslo, Norway. The arrangement was held at Norne Securities AS premises at Roald Amundsens gt. 6, Oslo. CEO Fredrik Palm gave an update of the company’s development during 2019 and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website. For further information, please contact ContextVision's CEO, Fredrik...